Statement from arranta bio on settlement of thermo fisher litigation

Watertown, mass.--(business wire)--arranta bio announced today that it has reached a settlement of its litigation with thermo fisher. the settlement follows an april 4, 2023 delaware court of chancery ruling that arranta bio was not subject to any non-competition obligations in its 2020 supply agreement with thermo fisher to develop plasmids. the specific terms of the settlement were not disclosed. the company offered the following statement: “arranta bio is pleased with the settlement and has.
TMO Ratings Summary
TMO Quant Ranking